Pharmaceutical stocks have not set the world on fire, with a few exceptions. Since the pandemic ended, pharma stocks have largely fallen out of favor with investors amid declining sales and mixed fina
Is Moderna stock a buy as the company looks to launch an updated Covid vaccine? Is MRNA stock a buy right now?
Moderna stock tumbled in late June after unveiling updated test results for its RSV vaccine. Is MRNA stock now a sell?
Moderna stock broke out of a cup-with-handle base after its first-quarter sales and earnings report. Is MRNA stock a buy right now?
Is Moderna stock a buy after unveiling promising results for its Pfizer- and GSK-rivaling RSV vaccine? Is MRNA stock a buy now?
Moderna stock fell after maintaining its 2024 outlook despite beating 2023 sales expectations. Is MRNA stock a buy or a sell right now?
Is Moderna stock a sell after its initial 2024 sales guidance widely misses expectations? Is MRNA stock a sell right now?
Is Moderna stock a buy after announcing promising results for its Merck-tied cancer vaccine? Is MRNA stock a buy right now?
Moderna stock soared on a strong fourth-quarter report that included unexpected earnings. Is MRNA stock a buy or a sell right now?
CAMBRIDGE, MA / ACCESSWIRE / July 10, 2024 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, August 1, 2024 to report its
Moderna (MRNA) reachead $116.07 at the closing of the latest trading day, reflecting a -0.33% change compared to its last close.
Top-ranked stocks Chewy (CHWY), Wingstop (WING), Moderna (MRNA), Tenet Healthcare (THC) and Kinross Gold (KGC) are likely to beat on the bottom line in their upcoming releases.
The outlook of many healthcare stocks is quite positive at this point. That's partly because many large investors have shunned the sector, since they believe that it is destined to produce horrible re

Bullish on LYV & Bearish on MRNA, NKE

01:18pm, Monday, 08'th Jul 2024
Live Nation (LYV), Moderna (MRNA), and Nike (NKE) are today's Big Three. Mike Short and Ben Lichtenstein discuss how to trade, as well as the technical trends of these stocks.
NEW YORK, July 07, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Moderna, Inc. (“Moderna” or the “Company”) (NASDAQ: MRNA). Such investors are advis
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE